首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Five questions that need answering when considering the design of clinical trials
【2h】

Five questions that need answering when considering the design of clinical trials

机译:在考虑临床试验设计时需要回答的五个问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer the research question, and why it is the best approach. It is especially important that researchers explain why the treatment difference sought is worthwhile to patients, and they should reference consultations with the public and patient groups and existing literature. Moreover, the study design should be underpinned by a systematic review of the existing evidence, which should be included in the research protocol. The Health Research Authority in collaboration with partners has published guidance entitled ‘Specific questions that need answering when considering the design of clinical trials’. The guidance will help those designing research and those reviewing it to address key issues.
机译:有证据表明,研究方案通常缺乏有关研究设计的重要信息,从而阻碍了外部评审。对于所提出的研究方法为何适合提出的问题,研究设计为何有可能回答研究问题以及为什么这是最佳方法,研究方案应提供充分的解释。研究人员解释为什么所寻求的治疗差异对患者而言是值得的,这一点尤其重要,他们应该参考与公众和患者团体的咨询以及现有文献。此外,研究设计应以对现有证据的系统评价为基础,并应包括在研究方案中。卫生研究局与合作伙伴合作发布了名为“在考虑临床试验设计时需要回答的特定问题”的指南。该指南将帮助那些设计研究和对其进行审查以解决关键问题的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号